|
Volumn 35, Issue 1, 2003, Pages 192-194
|
Randomised trial of simulect versus placebo for control of acute rejection in renal allograft recipients
|
Author keywords
[No Author keywords available]
|
Indexed keywords
AZATHIOPRINE;
BASILIXIMAB;
CYCLOSPORIN A;
HYDROCORTISONE;
INTERLEUKIN 2 RECEPTOR;
MONOCLONAL ANTIBODY;
PLACEBO;
PREDNISONE;
STEROID;
TUBERCULOSTATIC AGENT;
ADULT;
CADAVER DONOR;
CHILL;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONFERENCE PAPER;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
COUGHING;
CYTOKINE RELEASE;
DIABETES MELLITUS;
DRUG EFFECT;
DRUG TOLERABILITY;
FEMALE;
FEVER;
GRAFT REJECTION;
HEADACHE;
HUMAN;
HUMAN TISSUE;
HYPERTENSION;
INFECTION;
KIDNEY;
KIDNEY ALLOGRAFT;
KIDNEY FUNCTION;
LIVER FUNCTION;
LUNG EDEMA;
LYMPHOPROLIFERATIVE DISEASE;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
SIDE EFFECT;
TREATMENT OUTCOME;
TUBERCULOSIS;
|
EID: 0037321119
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/S0041-1345(02)03769-7 Document Type: Conference Paper |
Times cited : (7)
|
References (2)
|